NHL Extranodal Sites in HCV-Negative and -Positive Patients at Presentation
| NHL Sites . | HCV-Negative Patients . | HCV-Positive Patients . |
|---|---|---|
| . | (%) (n = 113) . | (%) (n = 37) . |
| Bone marrow | 27 | 29 |
| Spleen | 16 | 5 |
| Gastrointestinal tract | 9 | 3 |
| Waldeyer's ring | 8 | 3 |
| Breast | 3 | 0.8 |
| Liver | 2 | 0.8 |
| Skin/subcutaneous | 2 | 0.8 |
| Conjunctiva | 0.8 | — |
| Testis | 0.8 | — |
| Lung | 0.8 | — |
| NHL Sites . | HCV-Negative Patients . | HCV-Positive Patients . |
|---|---|---|
| . | (%) (n = 113) . | (%) (n = 37) . |
| Bone marrow | 27 | 29 |
| Spleen | 16 | 5 |
| Gastrointestinal tract | 9 | 3 |
| Waldeyer's ring | 8 | 3 |
| Breast | 3 | 0.8 |
| Liver | 2 | 0.8 |
| Skin/subcutaneous | 2 | 0.8 |
| Conjunctiva | 0.8 | — |
| Testis | 0.8 | — |
| Lung | 0.8 | — |